Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?

Detalles Bibliográficos
Autores principales: Wijaya, Indra, Andhika, Rizky, Huang, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362820/
https://www.ncbi.nlm.nih.gov/pubmed/32683322
http://dx.doi.org/10.1016/j.dsx.2020.07.015
_version_ 1783559564678922240
author Wijaya, Indra
Andhika, Rizky
Huang, Ian
author_facet Wijaya, Indra
Andhika, Rizky
Huang, Ian
author_sort Wijaya, Indra
collection PubMed
description
format Online
Article
Text
id pubmed-7362820
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Diabetes India. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73628202020-07-16 Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary? Wijaya, Indra Andhika, Rizky Huang, Ian Diabetes Metab Syndr Article Diabetes India. Published by Elsevier Ltd. 2020 2020-07-15 /pmc/articles/PMC7362820/ /pubmed/32683322 http://dx.doi.org/10.1016/j.dsx.2020.07.015 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wijaya, Indra
Andhika, Rizky
Huang, Ian
Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
title Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
title_full Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
title_fullStr Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
title_full_unstemmed Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
title_short Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
title_sort hypercoagulable state in covid-19 with diabetes mellitus and obesity: is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362820/
https://www.ncbi.nlm.nih.gov/pubmed/32683322
http://dx.doi.org/10.1016/j.dsx.2020.07.015
work_keys_str_mv AT wijayaindra hypercoagulablestateincovid19withdiabetesmellitusandobesityistherapeuticdoseorhigherdoseanticoagulantthromboprophylaxisnecessary
AT andhikarizky hypercoagulablestateincovid19withdiabetesmellitusandobesityistherapeuticdoseorhigherdoseanticoagulantthromboprophylaxisnecessary
AT huangian hypercoagulablestateincovid19withdiabetesmellitusandobesityistherapeuticdoseorhigherdoseanticoagulantthromboprophylaxisnecessary

Ejemplares similares